Senior Biotechnology Consultant
San Francisco Bay Area
University of California, San Francisco
Physician, Medical Internist + Hematologist
1986 to 2003
San Francisco Bay Area
Genentech
Global Cluster Head, Global Group Medical Director
2003 to 2010
Independent
Strategic Consultant
September 2017 to May 2018
Clovis Oncology
Vice President, Clinical Development
April 2010 to November 2012
San Francisco Bay Area
Bristol-Myers Squibb
Vice President, Head US Medical
May 2016 to September 2017
Princeton, New Jersey
Five Prime Therapeutics, Inc.
Executive Vice President, Chief Medical Officer
August 2015 to February 2016
Five Prime Therapeutics, Inc.
Senior VP, Chief Medical Officer
December 2012 to August 2015
South San Francisco
UCSF Medical Center
Hematology/Oncology; Director, Hemostasis and Thrombosis Service; Internal Medicine
1986 to 2003
SpringWorks Therapeutics
Member, Board of Directors
IDEAYA Biosciences
Chief Medical Officer, Head of Development
June 2018 to April 2020
South San Francisco, California
Arch Oncology
Member, Board of Directors
Hambleton Consulting, LLC
Senior Biotechnology Consultant
Onc.AI
Advisor
IGM Biosciences
Member, Board Of Directors
Mountain View, California
Medical Resident; Chief Medical Resident; Hematology/Oncology Fellow; 5 years in a PhD Biochemistry Lab; Recipient of NIH K-08 Award Medical Resident; Chief Medical Resident; Hematology/Oncology Fellow; 5 years in a PhD Biochemistry Lab; Recipient of NIH K-08 Award
đ Summary
Physician, Medical Internist + Hematologist @ University of California, San Francisco Medical Resident; Chief Medical Resident; Hematology/Oncology Fellow; 5 years in a PhD Biochemistry Lab; Recipient of NIH K-08 Award From 1986 to 2003 (17 years) San Francisco Bay AreaGlobal Cluster Head, Global Group Medical Director @ Genentech Oversaw global breast and ovarian cancer development program for Avastin which was running 7 global Phase III trials; Led Development team to secure FDA approval for Avastin in Renal Carcinoma and Glioblastoma (accelerated approval; presenter at FDA Oncology Drug Advisory Committee). Author of multiple Ph I-III trials; post-marketing commitments; abstracts and publications. Conducted Medical Affairs work; Spent 2 years in the pipeline group as clinical representative on 8 projects. Have managed multiple Medical Directors at various levels and clinical scientists, including overseeing a global team of 12 individuals when serving as Global Cluster Head. From 2003 to 2010 (7 years) Strategic Consultant @ Independent From September 2017 to May 2018 (9 months) Vice President, Clinical Development @ Clovis Oncology Oversaw clinical development of 2 programs - one in the pre-IND setting that entered Phase I in 2012, and the second program had 2 Phase I trials and a nascent medical affairs program. Served as clinical representative on the Business Development Team for in-licensing products. Managed 1 Medical Director, 1 PK Scientist and 2 Clinical Scientists. From April 2010 to November 2012 (2 years 8 months) San Francisco Bay AreaVice President, Head US Medical @ Bristol-Myers Squibb Head up the US Medical (Affairs) organization at BMS, with over 400 employees, across all therapeutic areas, including immuno-oncology/oncology, immunology, cardiovascular disease and virology. From May 2016 to September 2017 (1 year 5 months) Princeton, New JerseyExecutive Vice President, Chief Medical Officer @ Five Prime Therapeutics, Inc. From August 2015 to February 2016 (7 months) Senior VP, Chief Medical Officer @ Five Prime Therapeutics, Inc. As SVP/CMO, I sit on the Executive Committee and oversee both Nonclinical & Clinical Development, which includes Process Development, Pharmacology, Nonclinical Toxicology, Bioanalytics, Pharmacokinetic Sciences, Clinical, Drug Safety, Clinical Operations, and Regulatory. I was part of the IPO roadshow and follow-on team, presenting to and meeting with Investors, Analysts and Bankers. Our group has submitted 2 pre-IND packages and several CTA/IMPDs and initiated a Phase 1 trial in my first year at the company. From December 2012 to August 2015 (2 years 9 months) South San FranciscoHematology/Oncology; Director, Hemostasis and Thrombosis Service; Internal Medicine @ UCSF Medical Center Medical Director for inpatient and outpatient hemostasis & thrombosis service; Director, inpatient Hematology consult service; Director, Fellowship Training program; Research Subject Advocate, NIH-funded GCRC Unit From 1986 to 2003 (17 years) Member, Board of Directors @ SpringWorks Therapeutics Chief Medical Officer, Head of Development @ IDEAYA Biosciences From June 2018 to April 2020 (1 year 11 months) South San Francisco, CaliforniaMember, Board of Directors @ Arch Oncology Senior Biotechnology Consultant @ Hambleton Consulting, LLC Advisor @ Onc.AI Member, Board Of Directors @ IGM Biosciences Mountain View, California
What company does Julie Hambleton work for?
Julie Hambleton works for University of California, San Francisco
What is Julie Hambleton's role at University of California, San Francisco?
Julie Hambleton is Physician, Medical Internist + Hematologist
What industry does Julie Hambleton work in?
Julie Hambleton works in the Pharmaceuticals industry.
Who are Julie Hambleton's colleagues?
Julie Hambleton's colleagues are Tim Smith, Michael Dillon, Eleni Venetsanakos, Nori CPA, Yujiro Hata, Mark Lackner, and Bao Truong
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
5 year(s), 8 month(s)
Unlikely
Likely
There's 100% chance that Julie Hambleton is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Julie Hambleton's Social Media Links
/school/ca... /company/s...